Compass Ion Advisors, LLC Novartis Ag Transaction History
Compass Ion Advisors, LLC
- $773 Million
- Q4 2024
A detailed history of Compass Ion Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Compass Ion Advisors, LLC holds 2,575 shares of NVS stock, worth $288,091. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,575
Previous 2,657
3.09%
Holding current value
$288,091
Previous $305,000
18.03%
% of portfolio
0.03%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding NVS
# of Institutions
1,477Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.37 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.23 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$916 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$769 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$624 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $241B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...